Skip to main content

Advertisement

Log in

A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020

  • Guideline
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Acknowledgements

This study was supported in part by a Grant-in-Aid for Intractable Renal Diseases Research, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan.

aValues at the time of treatment initiation

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Hirokazu Okada.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

In 2020, the Research for Intractable Renal Diseases of the Ministry of Health, Labour and Welfare of Japan established the Committee of Guideline for Rapidly Progressive Glomerulonephritis, which published (A digest from evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020) on the website (jin-shogai.jp/policy/index.html). This is the English version of that digest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Usui, J., Kawashima, S., Sada, KE. et al. A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020. Clin Exp Nephrol 25, 1286–1291 (2021). https://doi.org/10.1007/s10157-021-02096-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-021-02096-7

Navigation